Public trial registry of the CCC-Munich

Trial CA209274

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CA209274
World
Full title
:

a Phase III, randomized, double-blind, multicenter study of adjuvant Nivolumab versus Placebo in subjects with high risc invasive urothel carcinoma

World
Responsible organization
:
Urologie MRI Ismaninger Str.22 81675 München Germany
Indications
Classification Code Description
- Other tumors
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Urologie MRI Ismaninger Str.22 81675 München Germany Magnifier